TransCode Therapeutics Inc.

About TransCode Therapeutics Inc.

TransCode Therapeutics, Inc. is a clinical-stage oncology company focused on treating metastatic disease. Their mission is to deliver a cancer-free future by targeting the mechanisms behind metastasis, an area often overlooked in cancer treatment.

Products & Services

TTX-MC138:Lead therapeutic candidate targeting microRNA-10b, a master regulator of metastasis. It is designed to treat metastatic cancer across over 18 cancer types, including breast, pancreatic, ovarian, and colon cancer, showing durable regression in pre-clinical studies.

TTX Delivery Platform:An iron oxide nanoparticle delivery system that is highly tunable to deliver therapeutic candidates to targets in tumors and metastases.

Other Products:Additional therapeutic candidates and diagnostics under development as part of the TTX investigational platform.

Specialties

Metastatic Disease Treatment microRNA Targeting Nanoparticle Delivery Systems Cancer Therapeutics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 10000000 MR: - FA: approximately $10 million FAN: 10000000	D: 2025-03-25 FD: 2025-03-25	-
2	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 10000000 MR: - FA: $10 million FAN: 10000000	D: 2025-03-23 FD: 2025-03-23	-
3	RT: Private Placement T: - FT: Private Placement	A: 8000000 MR: - FA: 8 million FAN: 8000000	D: 2024-11-27 FD: 2024-11-27	1 investors
4	RT: Grant T: - FT: Grant	A: 2000000 MR: - FA: $2 million FAN: 2000000	D: 2024-09-05 FD: 2024-09-05	1 investors
5	RT: Public Offering T: - FT: Public Offering	A: 3000000 MR: - FA: $3,000,000 FAN: 3000000	D: 2024-07-24 FD: 2024-07-24	1 investors
6	RT: Public Offering T: - FT: Public Offering	A: 3000000 MR: - FA: $3,000,000 FAN: 3000000	D: 2024-07-22 FD: 2024-07-22	-
7	RT: Public Offering T: - FT: Public Offering	A: 7250000 MR: - FA: $7.25 million FAN: 7250000	D: 2024-01-22 FD: 2024-01-22	1 investors
8	RT: Public Offering T: - FT: Public Offering	A: 7250000 MR: - FA: 7.25 million FAN: 7250000	D: 2024-01-18 FD: 2024-01-18	-
9	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 1200000 MR: - FA: $1.2 million FAN: 1200000	D: 2023-12-04 FD: 2023-12-04	1 investors
10	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 1200000 MR: - FA: $1.2 million FAN: 1200000	D: 2023-11-30 FD: 2023-11-30	1 investors
11	RT: Public Offering T: - FT: Public Offering	A: 8500000 MR: - FA: $8.5 million FAN: 8500000	D: 2023-09-28 FD: 2023-09-28	-
12	RT: Public Offering T: - FT: Public Offering	A: 7000000 MR: - FA: $7 million FAN: 7000000	D: 2023-06-09 FD: 2023-06-09	-
13	RT: Public Offering T: - FT: Public Offering	A: 7000000 MR: - FA: $7 million FAN: 7000000	D: 2023-06-06 FD: 2023-06-06	-
14	RT: Equity T: - FT: Equity	A: 1080000 MR: - FA: up to approximately $1.08 million FAN: 1080000	D: 2023-04-14 FD: 2023-04-14	1 investors
15	RT: SBIR Grant T: - FT: SBIR Grant	A: 871000 MR: - FA: nearly $871,000 FAN: 871000	D: 2023-04-05 FD: 2023-04-05	1 investors
16	RT: Series A T: - FT: Series A	A: 500000 MR: - FA: $500,000 FAN: 500000	D: 2023-04-03 FD: 2023-04-03	1 investors
17	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 1500000 MR: - FA: $1.5 million FAN: 1500000	D: 2023-02-17 FD: 2023-02-17	-
18	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 1500000 MR: - FA: 1.5 million FAN: 1500000	D: 2023-02-16 FD: 2023-02-16	1 investors

Registered Direct Offering Latest

2025-03-25

$10.0M

Registered Direct Offering 2025-03-23

$10.0M

Private Placement 2024-11-27

$8.0M

View 17 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Tom Fitzgerald

Interim CEO and CFO

S

Susan Duggan

Sr. VP of Operations

Z

Zdravka Medarova

Founder/Chief Scientific Officer

T

Tania Montgomery

Business Development

R

Ram Bhat

Sr. Director CMC

N

Neil Robertson

Senior Scientist

View 12 more team members with Pro

Unlock Full Team Directory

Recent News